← Back to Search

Lipoprotein(a) Screening for Cardiovascular Disease

N/A
Waitlist Available
Research Sponsored by Amgen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to approximately 2 weeks
Awards & highlights

Study Summary

This trial will help to understand the distribution of Lp(a) levels among people with a history of ASCVD, which will in turn help to improve ASCVD risk prediction models.

Who is the study for?
This study is for people who have a history of cardiovascular disease caused by atherosclerosis. Participants must have signed an informed consent form and not be on any investigational drugs or lipoprotein apheresis within the last 3 months, nor should they require dialysis due to end-stage renal disease.Check my eligibility
What is being tested?
The trial is focused on screening levels of lipoprotein(a), also known as Lp(a), in individuals with documented heart and artery diseases from atherosclerosis. It aims to understand how Lp(a) levels vary across different demographics and regions among these patients.See study design
What are the potential side effects?
Since this study involves only screening for Lp(a) levels without administering any medications or treatments, there are no direct side effects associated with the interventions being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to approximately 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to approximately 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with elevated Lp(a) with documented history of ASCVD
Secondary outcome measures
Lp(a) Levels
Lp(a) Levels stratified by demographics and region

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants with history of ASCVDExperimental Treatment1 Intervention
Participants with history of ASCVD with known or unknown Lp(a) values.

Find a Location

Who is running the clinical trial?

AmgenLead Sponsor
1,370 Previous Clinical Trials
1,338,208 Total Patients Enrolled
MDStudy DirectorAmgen
913 Previous Clinical Trials
884,651 Total Patients Enrolled

Media Library

Participants with history of ASCVD Clinical Trial Eligibility Overview. Trial Name: NCT05378529 — N/A
Cardiovascular Disease Clinical Trial 2023: Participants with history of ASCVD Highlights & Side Effects. Trial Name: NCT05378529 — N/A
Participants with history of ASCVD 2023 Treatment Timeline for Medical Study. Trial Name: NCT05378529 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are participating in this clinical trial?

"Amgen, the sponsor of this study, needs to enroll 20000 participants that meet the specified inclusion criteria. The trial will take place at South Texas Cardiovascular Consultants PLLC in San Antonio, Texas and Care Access Research Pebble Beach in Sun City, Florida."

Answered by AI

Could elderly individuals benefit from this medication research?

"The age criteria to participate in this clinical trial are between 18-85 years old."

Answered by AI

Who qualifies to participate in this research?

"The aim of this clinical trial is to test the efficacy of a new medication on patients that have cardiovascular diseases. Those who wish to participate must fall in the age range of 18 to 85. So far, around 20000 people have been recruited."

Answered by AI

Are new volunteers being accepted into this program at this time?

"The latest information from clinicaltrials.gov is that this trial is still open for recruitment. The study was first advertised on April 19th, 2022 and has had one update since then on November 2nd, 2022."

Answered by AI

How many research sites are participating in this study?

"The trial is being conducted out of South Texas Cardiovascular Consultants PLLC in San Antonio, Texas, Care Access Research Pebble Beach in Sun City, Florida, and Asheville Cardiology Associates in Asheville, North carolina. In addition to these 100 other locations."

Answered by AI

Who else is applying?

What site did they apply to?
Care Access Research Georgetown
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

i want to feel better.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022. "A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05378529.
~13160 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top